| PEGEX | PMBCX | PEGEX / PMBCX | |
| Total Expense Ratio | 1.08 | 1.71 | 63% |
| Annual Report Gross Expense Ratio | 1.28 | 1.71 | 75% |
| Fund Existence | 9 years | 20 years | - |
| Gain YTD | 4.969 | -1.341 | -371% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.71B | 23.2B | 7% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -4.97 | -12.23 | 41% |
| Returns for 3 years | 5.41 | 14.46 | 37% |
| Returns for 5 years | -30.43 | -8.99 | 338% |
| Returns for 10 years | N/A | 55.90 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GFLW | 34.14 | 0.21 | +0.63% |
| VictoryShares Free Cash Flow Growth ETF | |||
| AMVGX | 17.27 | 0.07 | +0.41% |
| American Century Mid Cap Value R5 | |||
| NAPIX | 84.40 | N/A | N/A |
| Voya Multi-Manager International Sm Cp I | |||
| FPHAX | 35.95 | N/A | N/A |
| Fidelity Select Pharmaceuticals Port | |||
| FEUCX | 22.05 | N/A | N/A |
| Fidelity Advisor Glbl Capital Apprec C | |||